pancreatic cystic lesions
Conditions
Interventions
A:EUS-guided ablation of pancreatic cystic lesions with 1% lauromacrogol injection
B: EUS-guided ablation of pancreatic cystic lesions with 2% lauromacrogol injection
C: EUS-guided ablation of pancreatic cystic lesions with 3% lauromacrogol injection
Sponsors
The First Medical Center of Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients with PCNs diagnosed by imaging, aged >= 18 years; 2. The lesion is not connected with the pancreatic duct; 3. EUS treatment was required for cyst enlargement and symptoms during SCNS follow-up; 4. MCNS excluded the possibility of malignancy; 5. Signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with pancreatitis or pancreatic pseudocyst; 2. Inability to tolerate intravenous anesthesia; 3. High risk of surgery: pregnancy, abnormal blood coagulation, serious cardiovascular diseases, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| size of the cyst before and after ablation;volume of the cyst before and after ablation; | — |
Secondary
| Measure | Time frame |
|---|---|
| amylase and lipase before and after ablation; | — |
Countries
China
Contacts
Public ContactEnqiang Linghu
The First Medical Center of PLA General Hospital
Outcome results
None listed